Archivo de la sección
Salud
Salud
CDC Cuts COVID-19 Isolation From 10 Days to 5 as Omicron Surge Strains Workplaces and Hospitals
Salud
FDA Authorizes Pfizer’s Paxlovid and Merck’s Molnupiravir, Adding Two At-Home Antiviral Pills as Omicron Surges
Salud
U.S. COVID-19 Death Toll Passes 800,000 as Cases and Hospitalizations Rise Into Winter
Salud
FDA and CDC Open Pfizer Boosters to 16- and 17-Year-Olds as Omicron Raises Pressure to Strengthen Immunity
Salud
First U.S. Omicron Case Confirmed in California as Officials Tighten Travel Testing and Race to Assess New Variant
Salud
WHO Names Omicron a Variant of Concern as Heavily Mutated Coronavirus Strain Triggers Global Surveillance and Travel Measures
Salud
U.S. Opens Pfizer and Moderna COVID-19 Boosters to All Adults as CDC Endorses Expanded Eligibility Before Holidays
Salud
Medicare Part B Premium Jumps $21.60 to $170.10 for 2022 as CMS Builds Reserve for Aduhelm Uncertainty
Salud
CDC Recommends Pfizer COVID-19 Vaccine for 28 Million Children Ages 5 to 11, Opening Pediatric Campaign
Salud
FDA Authorizes Pfizer COVID-19 Vaccine for 28 Million U.S. Children Ages 5 to 11
Salud
CDC Backs Moderna and Johnson & Johnson Boosters and Allows Mix-and-Match Doses Across All Three U.S. Vaccines
Salud
FDA Advisers Back Moderna and Johnson & Johnson Boosters, Moving U.S. Toward a Three-Vaccine Booster Strategy
Salud
Pfizer Seeks U.S. Authorization for COVID-19 Vaccine in 28 Million Children Ages 5 to 11
Salud
Merck Says Oral COVID-19 Drug Cut Hospitalization or Death by About 50% in Interim Phase 3 Trial
Salud
CDC Clears Pfizer Boosters for Seniors, High-Risk Adults and Workers With Frequent COVID-19 Exposure
Salud
FDA Advisers Reject Pfizer Boosters for Everyone 16 and Older, Back Third Doses for Seniors and High-Risk Adults
Salud
CDC Data Show Unvaccinated Adults Face About 10 Times the Hospitalization Risk and 11 Times the Death Risk During Delta
215 stories